Mexico
· Delayed Price · Currency is MXN Moderna Statistics
Total Valuation
Moderna has a market cap or net worth of MXN 335.69 billion. The enterprise value is 216.98 billion.
| Market Cap | 335.69B |
| Enterprise Value | 216.98B |
Important Dates
The next confirmed earnings date is Friday, May 1, 2026.
| Earnings Date | May 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 396.59M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.30% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 6.63% |
| Owned by Institutions (%) | 80.55% |
| Float | 369.96M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.59 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.27 |
| EV / Sales | 6.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.84 |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.15.
| Current Ratio | 3.29 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.63 |
| Interest Coverage | -307.40 |
Financial Efficiency
Return on equity (ROE) is -28.87% and return on invested capital (ROIC) is -63.28%.
| Return on Equity (ROE) | -28.87% |
| Return on Assets (ROA) | -14.51% |
| Return on Invested Capital (ROIC) | -63.28% |
| Return on Capital Employed (ROCE) | -29.70% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 7.45M |
| Profits Per Employee | -10.81M |
| Employee Count | 4,700 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 29.63 |
Taxes
In the past 12 months, Moderna has paid 972.17 million in taxes.
| Income Tax | 972.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +53.08% |
| 50-Day Moving Average | 891.24 |
| 200-Day Moving Average | 630.24 |
| Relative Strength Index (RSI) | 37.03 |
| Average Volume (20 Days) | 3,730 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.08 |
Income Statement
In the last 12 months, Moderna had revenue of MXN 35.00 billion and -50.81 billion in losses. Loss per share was -130.60.
| Revenue | 35.00B |
| Gross Profit | -37.01B |
| Operating Income | -55.34B |
| Pretax Income | -49.83B |
| Net Income | -50.81B |
| EBITDA | -51.47B |
| EBIT | -55.34B |
| Loss Per Share | -130.60 |
Balance Sheet
The company has 104.40 billion in cash and 23.49 billion in debt, giving a net cash position of 122.96 billion.
| Cash & Cash Equivalents | 104.40B |
| Total Debt | 23.49B |
| Net Cash | 122.96B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 155.73B |
| Book Value Per Share | 395.25 |
| Working Capital | 82.04B |
Cash Flow
In the last 12 months, operating cash flow was -33.72 billion and capital expenditures -3.46 billion, giving a free cash flow of -37.18 billion.
| Operating Cash Flow | -33.72B |
| Capital Expenditures | -3.46B |
| Depreciation & Amortization | 3.74B |
| Net Borrowing | 10.12B |
| Free Cash Flow | -37.18B |
| FCF Per Share | n/a |
Margins
Gross margin is -105.76%, with operating and profit margins of -158.13% and -145.16%.
| Gross Margin | -105.76% |
| Operating Margin | -158.13% |
| Pretax Margin | -142.39% |
| Profit Margin | -145.16% |
| EBITDA Margin | -147.07% |
| EBIT Margin | -158.13% |
| FCF Margin | n/a |
Dividends & Yields
Moderna does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.30% |
| Shareholder Yield | -1.30% |
| Earnings Yield | -15.13% |
| FCF Yield | -11.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Moderna has an Altman Z-Score of 2.44 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.44 |
| Piotroski F-Score | 1 |